JAMES SELLERS: Open Payments
NPI 1942761945 · ARROYO GRANDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 29 payments from 7 companies in 2025. Trend: 2023 $113 · 2024 $0 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Amgen Inc. | 2 | $36 |
| Philips North America LLC | 2 | $34 |
| Insmed, Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
Products named: TRELEGY ELLIPTA, NUCALA, FASENRA, TEZSPIRE, Vest Therapy Und, Arikayce, NUZYRA, OFEV.
Industry payments across CA — which companies pay providers there.
